About this trial
This research study aims to determine whether and how caffeine intake affects learning process through reward feedback compared to placebo. The data acquired from this study would improve our understanding on the consequence and mechanism of caffeine intake in the aspect of learning process.
Participants will perform a reinforcement learning task (i.e. Probabilistic Selection Task) and a motor inhibition task (i.e. Go/NoGo task) in a brain scan. The scan will be done with the Siemens Biograph mMR positron emission tomography (PET)/ magnetic resonance imaging (MRI) 3 Tesla scanner. The PET allows us to see the changes in the "reward signals" - dopamine - in the brain using a radioactive dye called \[11C\]Raclopride. The MRI, on the other hand, enables us to take detailed pictures of the brain activities during cognitive tasks using a high-powered magnet. Reviewing these pictures will help us understand the influence of caffeine on reward signals and brain activities during the learning process.
Eligibility criteria
Qualifiers
Age ≥ 18 and ≤ 45.
Habitual caffeine intake ≥ 100 mg and ≤ 450 mg daily.
Non-smokers.
Clinically healthy.
Disqualifiers
Pregnant or lactating women.
Women using hormonal contraceptives.
BMI < 18.5 or > 29.9
Sleep disturbance or extreme chronotype.
Trial design
Treatments tested in this trial
- Caffeine (200 mg)
- Placebo
Treatment groups
Sponsors and collaborators
Hsiao-Ying Wey
Lead sponsor
Martinos Center for Biomedical Imaging
Sponsor institution